Skip to main content
. Author manuscript; available in PMC: 2016 Jan 21.
Published in final edited form as: Expert Opin Investig Drugs. 2013 Nov 20;23(2):243–254. doi: 10.1517/13543784.2014.852536

Table 1.

GLYX-13 plasma concentration and pharmacokinetic parameters in normal human volunteers.

Dose (mg/kg) Cmax (µg/ml) AUC (µg·min/ml) t1/2 initial (min) Vd(l/kg) Cl (l/h/kg)
1 IV 5.2 ± 0.9 32 ± 4.2 4.7 ± 0.5 0.17 ± 0.03 2.02 ± 0.36
5 IV 26 ± 11 288 ±115 7.4 ± 0.9 0.31 ±0.14 2.09 ± 0.98
10 IV 100 ± 21 1162 ± 121 9.0 ± 0.6 0.12 ± 0.01 0.54 ± 0.05
20 IV 182 ± 56 4030 ± 405 14.0 ± 2.1 0.10 ± 0.03 0.30 ± 0.03

Pharmacokinetics parameters are presented as Mean ± SEM, n = 4 subjects at each dose.